Literature DB >> 17932313

Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.

Eiichiro Yamamoto1, Keiichiro Kataoka, Haruo Shintaku, Takuro Yamashita, Yoshiko Tokutomi, Yi-Fei Dong, Shinji Matsuba, Hidenori Ichijo, Hisao Ogawa, Shokei Kim-Mitsuyama.   

Abstract

OBJECTIVE: The mechanism and role of angiotensin II-induced vascular endothelial injury is unclear. We examined the molecular mechanism of angiotensin (AII)-induced vascular endothelial injury and its significance for hypertensive diastolic heart failure. METHODS AND
RESULTS: We compared the effect of valsartan and amlodipine on Dahl salt-sensitive hypertensive rats (DS rats). Valsartan improved vascular endothelial dysfunction of DS rats more than amlodipine, by inhibiting endothelial apoptosis and eNOS uncoupling more. Moreover, valsartan inhibited vascular apoptosis signal-regulating kinase 1 (ASK1) more than amlodipine. Thus, AT1 receptor contributed to vascular endothelial apoptosis, eNOS uncoupling, and ASK1 activation of DS rats. Using ASK1(-/-) mice, we examined the causative role of ASK1 in endothelial apoptosis and eNOS uncoupling. AII infusion in wild-type mice markedly caused vascular endothelial apoptosis and eNOS uncoupling accompanied by vascular endothelial dysfunction, whereas these effects of AII were absent in ASK1(-/-) mice. Therefore, ASK1 participated in AII-induced vascular endothelial apoptosis and eNOS uncoupling. Using tetrahydrobiopterin, we found that eNOS uncoupling was involved in vascular endothelial dysfunction in DS rats with established diastolic heart failure.
CONCLUSIONS: AII-induced vascular endothelial apoptosis and eNOS uncoupling were mediated by ASK1 and contributed to vascular injury in diastolic heart failure of salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932313     DOI: 10.1161/ATVBAHA.107.153692

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Vascular responses to 8-nitro-cyclic GMP in non-diabetic and diabetic mice.

Authors:  Yoshiko Tokutomi; Keiichiro Kataoka; Eiichiro Yamamoto; Taishi Nakamura; Masaya Fukuda; Hisato Nako; Kensuke Toyama; Yi-Fei Dong; Khandaker Ahtesham Ahmed; Tomohiro Sawa; Takaaki Akaike; Shokei Kim-Mitsuyama
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction.

Authors:  Gad A Silberman; Tai-Hwang M Fan; Hong Liu; Zhe Jiao; Hong D Xiao; Joshua D Lovelock; Beth M Boulden; Julian Widder; Scott Fredd; Kenneth E Bernstein; Beata M Wolska; Sergey Dikalov; David G Harrison; Samuel C Dudley
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

3.  Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes.

Authors:  Y F Dong; L Liu; K Kataoka; T Nakamura; M Fukuda; Y Tokutomi; H Nako; H Ogawa; S Kim-Mitsuyama
Journal:  Diabetologia       Date:  2009-11-06       Impact factor: 10.122

4.  Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension.

Authors:  E M Seymour; Andrew A M Singer; Maurice R Bennink; Rushi V Parikh; Ara Kirakosyan; Peter B Kaufman; Steven F Bolling
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-10       Impact factor: 6.053

5.  Inhibition of ubiquitin protein expression and 20S proteasome activity by irbesartan prevents post-infarction ventricular remodeling and decreases TNF-α generation.

Authors:  Naiju Zhang; Tianping Chen; Chunfang Liu; Bi Tang; Ling Nie; Huiling An; Duilan Zhao; Li Pan; Meiling Yu
Journal:  Biomed Rep       Date:  2013-09-12

6.  Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.

Authors:  Eiichiro Yamamoto; Keiichiro Kataoka; Yi-Fei Dong; Nobutaka Koibuchi; Kensuke Toyama; Daisuke Sueta; Tetsuji Katayama; Osamu Yasuda; Hisao Ogawa; Shokei Kim-Mitsuyama
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

7.  Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces endothelial cytokine production without improving permeability after toll-like receptor 4 (TLR4) challenge.

Authors:  Michael R Miller; Stephen R Koch; Hyehun Choi; Fred S Lamb; Ryan J Stark
Journal:  Transl Res       Date:  2021-04-20       Impact factor: 10.171

8.  A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

Authors:  Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

9.  Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.

Authors:  Grazia Esposito; Donato Cappetta; Rosa Russo; Alessia Rivellino; Loreta Pia Ciuffreda; Fiorentina Roviezzo; Elena Piegari; Liberato Berrino; Francesco Rossi; Antonella De Angelis; Konrad Urbanek
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

Review 10.  Therapeutic targets in the ASK1-dependent stress signaling pathways.

Authors:  Ryoichi Hayakawa; Teruyuki Hayakawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.